Rivaroxaban for preventing adverse outcomes after acute management of acute coronary

publication of the final draft guidance. 5.3 When NICE recommends a treatment 'as an option', the NHS must make sure it is available within the period set out in the paragraphs above. This means that, if a patient has had acute management of acute coronary syndrome and the healthcare professional responsible for their care thinks that rivaroxaban is the right treatment, it should be available for use, in line with NICE's recommendations.
